Press Releases

Customized menu will include micro-roasted coffee and espresso drinks, wraps, soups and salads
Friday, November 17, 2017

BUFFALO, N.Y. — In early 2018, SPoT Coffee will serve its first customer at a new location inside Roswell Park Cancer Institute. This newest SPoT location will be a 500-net-square-foot “SPoT Coffee Express” café centrally located for the convenience of Roswell Park patients, visitors and employees within the comprehensive cancer center’s main lobby at Elm and Carlton Streets in Buffalo.

In partnership with the Courage of Carly Fund at Roswell Park
Thursday, November 16, 2017
The Buffalo Sabres today announced that the team will again take part in the NHL Hockey Fights Cancer™ program, in partnership with the Courage of Carly Fund at Roswell Park Cancer Institute, during the team’s home game on Saturday, Nov. 18, at 7 p.m. against the Carolina Hurricanes.
Fully supported, 500+ mile, 7-day cycling adventure across New York State aims to raise $1 million for cancer research
Thursday, November 9, 2017
Registration for the 2018 Empire State Ride is now open. This year’s event anticipates more than 200 individuals from across the country will embark on this fully supported, 500+ mile, seven-day bicycling event across New York State with one mission: to end cancer.
Wednesday, November 8, 2017
Roswell Park and the Buffalo Sabres are teaming up to offer free prostate cancer early detection for eligible men. The Nov. 14 event, the latest in the joint One Team, One Goal: Together to Beat Cancer initiative, is part of an ongoing effort to reduce cancer’s impact among the team’s fans through prevention, education and early detection.
Saturday, November 4, 2017
Amy Robach of "Good Morning America" was honored Saturday evening at the 27th annual All Star Night, Roswell Park Cancer Institute’s signature black-tie gala, for the extraordinary courage she has shown in the face of her breast cancer battle.
Thursday, November 2, 2017
Researchers at Roswell Park Cancer Institute have initiated a clinical trial based on a unique two-pronged strategy for arming the immune system to more effectively attack cancer cells. Patients treated through this early-stage clinical trial, which is available only at Roswell Park, will receive one-time injections of their own cells —“super T cells” reprogrammed to make them more effective at targeting tumor cells, and armed with an added element to help them to evade one of cancer’s most resilient defenses.
Wednesday, November 1, 2017
Roswell Park Cancer Institute has again been honored by the Press Ganey organization for consistent superior performance in the area of patient experience. The comprehensive cancer center has received Press Ganey’s Guardian of Excellence Award for the third year in a row based on its sustained ranking among the top 5% of hospitals for patient satisfaction related to inpatient care.
Tuesday, October 24, 2017
One of the most important areas of cancer research today involves efforts to expand the benefits of immunotherapy to more patients. Research conducted by scientists at Roswell Park Cancer Institute in cooperation with Panacela Labs LLC, a subsidiary of Cleveland BioLabs LLC (Nasdaq: CBLI), introduces a new class of immunotherapy and proposes a strategy for increasing the number of patients who are likely to benefit from this new approach.
Monday, October 16, 2017

A newly awarded grant will enable easier, more interactive access to medical records for Roswell Park Cancer Institute patients. The comprehensive cancer center will become one of the first centers anywhere in New York State to implement the OpenNotes concept and integrate note-sharing into its secure digital portal, MyRoswell, thanks to a $125,000 award from the New York State Health Foundation.

Friday, September 29, 2017

Roswell Park Cancer Institute researcher and faculty member Rodney Haring,PhD MSW , has been recognized with a 2017 Area/Regional Impact Award from the National Indian Health Board (NIHB).

Thursday, September 28, 2017

BUFFALO, N.Y. — A treatment that works well for one cancer type can possibly make other cancers grow more quickly. That is the striking implication of new research from a team at Roswell Park Cancer Institute, published in the journal Cell Reports.

Tuesday, September 19, 2017

Researchers at Roswell Park Cancer Institute recently received more than $6.8 million in grant awards to support six specific projects aimed at improving supportive care and developing new immunotherapy and targeted therapy treatment approaches.